Dr. Peter Creticos, M.D

NPI: 1225085301
Total Payments
$61,242
2023 Payments
$3,855
Companies
4
Transactions
36

Payment Breakdown by Category

Consulting$50,967 (83.2%)
Travel$5,917 (9.7%)
Other$3,000 (4.9%)
Food & Beverage$1,012 (1.7%)
Research$346.21 (0.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $50,967 14 83.2%
Travel and Lodging $5,917 5 9.7%
Honoraria $3,000 2 4.9%
Food and Beverage $1,012 13 1.7%
Unspecified $346.21 2 0.6%

Payments by Type

General
$60,896
34 transactions
Research
$346.21
2 transactions

Top Paying Companies

Company Total Records Latest Year
Greer Laboratories, Inc. $39,925 16 $0 (2017)
Regeneron Pharmaceuticals, Inc. $17,713 11 $0 (2023)
ALK-Abello, Inc $3,592 8 $0 (2022)
Novartis Pharmaceuticals Corporation $12.48 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2023 $3,855 3 Regeneron Pharmaceuticals, Inc. ($3,855)
2022 $6,233 5 Regeneron Pharmaceuticals, Inc. ($4,371)
2021 $4,938 2 Regeneron Pharmaceuticals, Inc. ($3,738)
2020 $5,750 4 Regeneron Pharmaceuticals, Inc. ($5,750)
2019 $262.36 3 ALK-Abello, Inc ($262.36)
2018 $267.60 2 ALK-Abello, Inc ($267.60)
2017 $39,937 17 Greer Laboratories, Inc. ($39,925)

All Payment Transactions

36 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
05/05/2023 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $3,261.50 General
05/05/2023 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $296.50 General
05/05/2023 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $296.50 General
09/09/2022 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $4,025.00 General
06/04/2022 Regeneron Pharmaceuticals, Inc. In-kind items and services $225.13 Research
Study: A Single Dose Study of the Efficacy, Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic Rhinitis Subjects Challenged Intranasally With Allergen Extract
05/11/2022 ALK-Abello, Inc Ragwitek (Drug) Food and Beverage In-kind items and services $61.94 General
Category: Allergy and Immunology
05/04/2022 ALK-Abello, Inc Ragwitek (Drug) Honoraria Cash or cash equivalent $1,800.00 General
Category: Allergy and Immunology
04/26/2022 Regeneron Pharmaceuticals, Inc. In-kind items and services $121.08 Research
Study: A Single Dose Study of the Efficacy, Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic Rhinitis Subjects Challenged Intranasally With Allergen Extract
12/10/2021 ALK-Abello, Inc Honoraria Cash or cash equivalent $1,200.00 General
04/23/2021 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $3,737.50 General
11/06/2020 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $2,875.00 General
11/06/2020 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $1,150.00 General
11/06/2020 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $1,150.00 General
11/06/2020 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $575.00 General
12/11/2019 ALK-Abello, Inc Odactra (Drug) Food and Beverage In-kind items and services $56.41 General
Category: Allergy and Immunology
02/23/2019 ALK-Abello, Inc Odactra (Drug), Ragwitek, Grastek Food and Beverage In-kind items and services $117.00 General
Category: Allergy and Immunology
01/22/2019 ALK-Abello, Inc Odactra (Drug) Food and Beverage In-kind items and services $88.95 General
Category: Allergy and Immunology
11/17/2018 ALK-Abello, Inc Odactra (Drug) Food and Beverage In-kind items and services $102.17 General
Category: Allergy and Immunology
03/01/2018 ALK-Abello, Inc Odactra (Drug) Food and Beverage In-kind items and services $165.43 General
Category: Allergy and Immunology
12/14/2017 Greer Laboratories, Inc. Consulting Fee Cash or cash equivalent $15,850.00 General
12/14/2017 Greer Laboratories, Inc. Travel and Lodging Cash or cash equivalent $188.80 General
12/14/2017 Greer Laboratories, Inc. Food and Beverage In-kind items and services $5.87 General
07/19/2017 Greer Laboratories, Inc. Travel and Lodging Cash or cash equivalent $2,301.60 General
07/19/2017 Greer Laboratories, Inc. Consulting Fee Cash or cash equivalent $2,250.00 General
05/22/2017 Greer Laboratories, Inc. Oralair (Drug) Food and Beverage In-kind items and services $32.62 General
Category: Allergy

Research Studies & Clinical Trials

Study Name Company Amount Records
A Single Dose Study of the Efficacy, Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic Rhinitis Subjects Challenged Intranasally With Allergen Extract Regeneron Pharmaceuticals, Inc. $346.21 2

About Dr. Peter Creticos, M.D

Dr. Peter Creticos, M.D is a Allergy healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225085301.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Creticos, M.D has received a total of $61,242 in payments from pharmaceutical and medical device companies, with $3,855 received in 2023. These payments were reported across 36 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($50,967).

Practice Information

  • Specialty Allergy
  • Location Baltimore, MD
  • Active Since 05/27/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 207KA0200X
  • Entity Type Individual
  • NPI Number 1225085301

Products in Payments

  • Ragwitek (Drug) $1,862
  • Odactra (Drug) $529.96
  • Oralair (Drug) $152.12
  • XOLAIR (Biological) $12.48

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Allergy Doctors in Baltimore